JP2008533990A

JP2008533990A - インフルエンザ治療剤

インフルエンザ治療剤 Download PDF

Info

Publication number: JP2008533990A
Authority: JP; Japan
Prior art keywords: rnai; seq; virus; inducing substance; inducing
Prior art date: 2005-03-22
Legal status : Pending

Application number

JP2008503156A

Other languages

English (en)

Japanese (ja)

Other versions

JP2008533990A5 (enExample

Inventor

チアンチュチェン，

チンゲー，

ハーマンエヌ．エイゼン，

Current Assignee

Massachusetts Institute of Technology

Original Assignee

Massachusetts Institute of Technology

Priority date

2005-03-22

Filing date

2006-03-22

Publication date

2008-08-28

2005-04-08 Priority claimed from US11/102,097 external-priority patent/US20060160759A1/en

2006-03-22 Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology

2008-08-28 Publication of JP2008533990A publication Critical patent/JP2008533990A/ja

2009-05-14 Publication of JP2008533990A5 publication Critical patent/JP2008533990A5/ja

Status Pending legal-status Critical Current

Links

206010022000 influenza Diseases 0.000 title claims abstract description 54
238000011282 treatment Methods 0.000 title description 28
230000009368 gene silencing by RNA Effects 0.000 claims abstract description 459
230000001939 inductive effect Effects 0.000 claims abstract description 384
241000712461 unidentified influenza virus Species 0.000 claims abstract description 238
150000007523 nucleic acids Chemical class 0.000 claims abstract description 200
239000003795 chemical substances by application Substances 0.000 claims abstract description 184
239000000203 mixture Substances 0.000 claims abstract description 184
238000000034 method Methods 0.000 claims abstract description 179
230000000295 complement effect Effects 0.000 claims abstract description 175
102000039446 nucleic acids Human genes 0.000 claims abstract description 169
108020004707 nucleic acids Proteins 0.000 claims abstract description 169
238000012384 transportation and delivery Methods 0.000 claims abstract description 73
241000282414 Homo sapiens Species 0.000 claims abstract description 48
210000004072 lung Anatomy 0.000 claims abstract description 39
210000000056 organ Anatomy 0.000 claims abstract description 23
108091030071 RNAI Proteins 0.000 claims abstract 84
239000004055 small Interfering RNA Substances 0.000 claims description 305
108020004459 Small interfering RNA Proteins 0.000 claims description 300
239000000126 substance Substances 0.000 claims description 168
241000700605 Viruses Species 0.000 claims description 151
125000003729 nucleotide group Chemical group 0.000 claims description 143
239000002773 nucleotide Substances 0.000 claims description 132
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 119
108090000623 proteins and genes Proteins 0.000 claims description 102
239000013598 vector Substances 0.000 claims description 93
238000004519 manufacturing process Methods 0.000 claims description 77
230000014509 gene expression Effects 0.000 claims description 76
108091027967 Small hairpin RNA Proteins 0.000 claims description 66
208000015181 infectious disease Diseases 0.000 claims description 63
210000002345 respiratory system Anatomy 0.000 claims description 57
102000011931 Nucleoproteins Human genes 0.000 claims description 55
108010061100 Nucleoproteins Proteins 0.000 claims description 55
230000002401 inhibitory effect Effects 0.000 claims description 53
229920006317 cationic polymer Polymers 0.000 claims description 47
238000013518 transcription Methods 0.000 claims description 47
230000035897 transcription Effects 0.000 claims description 47
238000003556 assay Methods 0.000 claims description 45
230000005764 inhibitory process Effects 0.000 claims description 44
230000009385 viral infection Effects 0.000 claims description 44
241001465754 Metazoa Species 0.000 claims description 43
239000000523 sample Substances 0.000 claims description 37
229920000642 polymer Polymers 0.000 claims description 33
238000001890 transfection Methods 0.000 claims description 29
230000009261 transgenic effect Effects 0.000 claims description 26
230000000241 respiratory effect Effects 0.000 claims description 25
101710102873 Polymerase basic protein 2 Proteins 0.000 claims description 24
230000037396 body weight Effects 0.000 claims description 23
229940124447 delivery agent Drugs 0.000 claims description 23
239000012634 fragment Substances 0.000 claims description 20
239000003814 drug Substances 0.000 claims description 18
210000005166 vasculature Anatomy 0.000 claims description 15
108700005077 Viral Genes Proteins 0.000 claims description 13
-1 amino ester Chemical class 0.000 claims description 13
230000008859 change Effects 0.000 claims description 13
150000002632 lipids Chemical class 0.000 claims description 12
230000002708 enhancing effect Effects 0.000 claims description 11
210000002919 epithelial cell Anatomy 0.000 claims description 10
238000002347 injection Methods 0.000 claims description 10
239000007924 injection Substances 0.000 claims description 10
101150118742 NP gene Proteins 0.000 claims description 6
210000001552 airway epithelial cell Anatomy 0.000 claims description 6
230000002792 vascular Effects 0.000 claims description 6
238000009007 Diagnostic Kit Methods 0.000 claims description 5
101150105115 PA gene Proteins 0.000 claims description 5
101150103639 PB1 gene Proteins 0.000 claims description 5
101150030427 PB2 gene Proteins 0.000 claims description 5
241000271566 Aves Species 0.000 abstract description 27
241001500351 Influenzavirus A Species 0.000 abstract description 9
230000004071 biological effect Effects 0.000 abstract 1
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 375
210000004027 cell Anatomy 0.000 description 188
230000000692 anti-sense effect Effects 0.000 description 124
108020004999 messenger RNA Proteins 0.000 description 72
230000003612 virological effect Effects 0.000 description 61
108020000999 Viral RNA Proteins 0.000 description 54
239000002585 base Substances 0.000 description 52
108091081021 Sense strand Proteins 0.000 description 43
241000712431 Influenza A virus Species 0.000 description 41
239000003184 complementary RNA Substances 0.000 description 41
108020004394 Complementary RNA Proteins 0.000 description 40
239000002245 particle Substances 0.000 description 37
101710154606 Hemagglutinin Proteins 0.000 description 35
101710093908 Outer capsid protein VP4 Proteins 0.000 description 35
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 35
101710176177 Protein A56 Proteins 0.000 description 35
230000000694 effects Effects 0.000 description 35
239000000185 hemagglutinin Substances 0.000 description 35
230000015572 biosynthetic process Effects 0.000 description 34
230000000875 corresponding effect Effects 0.000 description 33
150000001875 compounds Chemical class 0.000 description 31
238000003786 synthesis reaction Methods 0.000 description 30
241000894007 species Species 0.000 description 29
210000001519 tissue Anatomy 0.000 description 29
102000004169 proteins and genes Human genes 0.000 description 27
108091034117 Oligonucleotide Proteins 0.000 description 26
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
235000018102 proteins Nutrition 0.000 description 26
230000008685 targeting Effects 0.000 description 25
102000040650 (ribonucleotides)n+m Human genes 0.000 description 24
241000282412 Homo Species 0.000 description 23
238000009472 formulation Methods 0.000 description 23
238000003199 nucleic acid amplification method Methods 0.000 description 23
108020004414 DNA Proteins 0.000 description 22
230000003321 amplification Effects 0.000 description 22
239000000411 inducer Substances 0.000 description 21
108010006232 Neuraminidase Proteins 0.000 description 20
102000005348 Neuraminidase Human genes 0.000 description 20
241000287828 Gallus gallus Species 0.000 description 19
230000015556 catabolic process Effects 0.000 description 19
238000006731 degradation reaction Methods 0.000 description 19
201000010099 disease Diseases 0.000 description 19
235000013330 chicken meat Nutrition 0.000 description 18
230000001965 increasing effect Effects 0.000 description 18
239000000463 material Substances 0.000 description 18
238000012986 modification Methods 0.000 description 18
238000013461 design Methods 0.000 description 17
230000004048 modification Effects 0.000 description 17
230000014616 translation Effects 0.000 description 17
238000009396 hybridization Methods 0.000 description 15
210000004962 mammalian cell Anatomy 0.000 description 15
230000002829 reductive effect Effects 0.000 description 15
230000001105 regulatory effect Effects 0.000 description 15
241000699670 Mus sp. Species 0.000 description 14
239000012530 fluid Substances 0.000 description 14
238000000338 in vitro Methods 0.000 description 14
208000037797 influenza A Diseases 0.000 description 14
238000012545 processing Methods 0.000 description 14
238000013519 translation Methods 0.000 description 14
229920002873 Polyethylenimine Polymers 0.000 description 13
238000001727 in vivo Methods 0.000 description 13
238000001990 intravenous administration Methods 0.000 description 13
230000007246 mechanism Effects 0.000 description 13
230000001404 mediated effect Effects 0.000 description 13
108090000765 processed proteins & peptides Proteins 0.000 description 13
230000010076 replication Effects 0.000 description 13
108091028043 Nucleic acid sequence Proteins 0.000 description 12
108700019146 Transgenes Proteins 0.000 description 12
238000013459 approach Methods 0.000 description 12
230000001413 cellular effect Effects 0.000 description 12
235000013601 eggs Nutrition 0.000 description 12
238000004520 electroporation Methods 0.000 description 12
239000013612 plasmid Substances 0.000 description 12
239000000843 powder Substances 0.000 description 12
208000024891 symptom Diseases 0.000 description 12
229960005486 vaccine Drugs 0.000 description 12
230000029812 viral genome replication Effects 0.000 description 12
239000002777 nucleoside Substances 0.000 description 11
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 10
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
208000036142 Viral infection Diseases 0.000 description 10
239000000427 antigen Substances 0.000 description 10
238000003776 cleavage reaction Methods 0.000 description 10
238000001514 detection method Methods 0.000 description 10
238000011156 evaluation Methods 0.000 description 10
239000003112 inhibitor Substances 0.000 description 10
238000003752 polymerase chain reaction Methods 0.000 description 10
230000009467 reduction Effects 0.000 description 10
230000007017 scission Effects 0.000 description 10
239000000443 aerosol Substances 0.000 description 9
108091007433 antigens Proteins 0.000 description 9
102000036639 antigens Human genes 0.000 description 9
125000002091 cationic group Chemical group 0.000 description 9
230000006870 function Effects 0.000 description 9
230000035772 mutation Effects 0.000 description 9
239000008194 pharmaceutical composition Substances 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
238000003753 real-time PCR Methods 0.000 description 9
238000010839 reverse transcription Methods 0.000 description 9
239000000243 solution Substances 0.000 description 9
241000282887 Suidae Species 0.000 description 8
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
238000010521 absorption reaction Methods 0.000 description 8
239000013543 active substance Substances 0.000 description 8
230000007423 decrease Effects 0.000 description 8
238000005259 measurement Methods 0.000 description 8
102000004196 processed proteins & peptides Human genes 0.000 description 8
230000001225 therapeutic effect Effects 0.000 description 8
238000012546 transfer Methods 0.000 description 8
210000002845 virion Anatomy 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
241000124008 Mammalia Species 0.000 description 7
108700011259 MicroRNAs Proteins 0.000 description 7
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
208000035475 disorder Diseases 0.000 description 7
241001493065 dsRNA viruses Species 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
239000012678 infectious agent Substances 0.000 description 7
239000007788 liquid Substances 0.000 description 7
239000002609 medium Substances 0.000 description 7
210000004940 nucleus Anatomy 0.000 description 7
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 7
229920000729 poly(L-lysine) polymer Polymers 0.000 description 7
230000008569 process Effects 0.000 description 7
239000002904 solvent Substances 0.000 description 7
239000004094 surface-active agent Substances 0.000 description 7
239000013603 viral vector Substances 0.000 description 7
241000283086 Equidae Species 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000012228 culture supernatant Substances 0.000 description 6
229940079593 drug Drugs 0.000 description 6
238000005516 engineering process Methods 0.000 description 6
230000036541 health Effects 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
210000004185 liver Anatomy 0.000 description 6
239000002679 microRNA Substances 0.000 description 6
150000003833 nucleoside derivatives Chemical class 0.000 description 6
239000000546 pharmaceutical excipient Substances 0.000 description 6
229920000724 poly(L-arginine) polymer Polymers 0.000 description 6
230000002265 prevention Effects 0.000 description 6
230000001177 retroviral effect Effects 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
108020005345 3' Untranslated Regions Proteins 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
208000002979 Influenza in Birds Diseases 0.000 description 5
101710144128 Non-structural protein 2 Proteins 0.000 description 5
101710199667 Nuclear export protein Proteins 0.000 description 5
238000002123 RNA extraction Methods 0.000 description 5
239000002253 acid Substances 0.000 description 5
150000007513 acids Chemical class 0.000 description 5
206010064097 avian influenza Diseases 0.000 description 5
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
231100000135 cytotoxicity Toxicity 0.000 description 5
230000003013 cytotoxicity Effects 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
230000003834 intracellular effect Effects 0.000 description 5
239000000178 monomer Substances 0.000 description 5
210000000214 mouth Anatomy 0.000 description 5
210000001331 nose Anatomy 0.000 description 5
125000003835 nucleoside group Chemical group 0.000 description 5
239000002243 precursor Substances 0.000 description 5
230000002685 pulmonary effect Effects 0.000 description 5
125000002652 ribonucleotide group Chemical group 0.000 description 5
239000007921 spray Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
230000032258 transport Effects 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
241000272525 Anas platyrhynchos Species 0.000 description 4
239000004475 Arginine Substances 0.000 description 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
108010042407 Endonucleases Proteins 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
102000014150 Interferons Human genes 0.000 description 4
108010050904 Interferons Proteins 0.000 description 4
108060001084 Luciferase Proteins 0.000 description 4
239000005089 Luciferase Substances 0.000 description 4
108090001074 Nucleocapsid Proteins Proteins 0.000 description 4
241000286209 Phasianidae Species 0.000 description 4
206010062106 Respiratory tract infection viral Diseases 0.000 description 4
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
108010067390 Viral Proteins Proteins 0.000 description 4
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
238000010171 animal model Methods 0.000 description 4
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
230000027455 binding Effects 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
229920001577 copolymer Polymers 0.000 description 4
210000000805 cytoplasm Anatomy 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
238000011161 development Methods 0.000 description 4
238000002405 diagnostic procedure Methods 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
239000003937 drug carrier Substances 0.000 description 4
210000001163 endosome Anatomy 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
210000003743 erythrocyte Anatomy 0.000 description 4
230000030279 gene silencing Effects 0.000 description 4
238000001415 gene therapy Methods 0.000 description 4
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
230000003993 interaction Effects 0.000 description 4
229940079322 interferon Drugs 0.000 description 4
239000007922 nasal spray Substances 0.000 description 4
XRQDFNLINLXZLB-CKIKVBCHSA-N peramivir Chemical compound CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(O)=O)C[C@H]1NC(N)=N XRQDFNLINLXZLB-CKIKVBCHSA-N 0.000 description 4
229960001084 peramivir Drugs 0.000 description 4
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
229920001184 polypeptide Polymers 0.000 description 4
239000000047 product Substances 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
238000012385 systemic delivery Methods 0.000 description 4
238000012360 testing method Methods 0.000 description 4
229930024421 Adenine Natural products 0.000 description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
102100031780 Endonuclease Human genes 0.000 description 3
102100023387 Endoribonuclease Dicer Human genes 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
101000907904 Homo sapiens Endoribonuclease Dicer Proteins 0.000 description 3
206010061598 Immunodeficiency Diseases 0.000 description 3
241000713196 Influenza B virus Species 0.000 description 3
102100034349 Integrase Human genes 0.000 description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
101710163270 Nuclease Proteins 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
239000003242 anti bacterial agent Substances 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
239000003443 antiviral agent Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
230000005540 biological transmission Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000002775 capsule Substances 0.000 description 3
229910002091 carbon monoxide Inorganic materials 0.000 description 3
230000004700 cellular uptake Effects 0.000 description 3
108091036078 conserved sequence Proteins 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
210000002257 embryonic structure Anatomy 0.000 description 3
125000005843 halogen group Chemical group 0.000 description 3
229960002885 histidine Drugs 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
125000002883 imidazolyl group Chemical group 0.000 description 3
230000006698 induction Effects 0.000 description 3
208000037798 influenza B Diseases 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
239000003446 ligand Substances 0.000 description 3
210000002540 macrophage Anatomy 0.000 description 3
210000001161 mammalian embryo Anatomy 0.000 description 3
108091070501 miRNA Proteins 0.000 description 3
238000000520 microinjection Methods 0.000 description 3
229940097496 nasal spray Drugs 0.000 description 3
210000004738 parenchymal cell Anatomy 0.000 description 3
230000037361 pathway Effects 0.000 description 3
210000003800 pharynx Anatomy 0.000 description 3
238000001243 protein synthesis Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
230000004044 response Effects 0.000 description 3
238000003757 reverse transcription PCR Methods 0.000 description 3
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
230000001629 suppression Effects 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000003826 tablet Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
210000003437 trachea Anatomy 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
230000017613 viral reproduction Effects 0.000 description 3
125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
108700028369 Alleles Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
108010041986 DNA Vaccines Proteins 0.000 description 2
229940021995 DNA vaccine Drugs 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
101710121417 Envelope glycoprotein Proteins 0.000 description 2
241000283073 Equus caballus Species 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
241000713297 Influenza C virus Species 0.000 description 2
108090000862 Ion Channels Proteins 0.000 description 2
102000004310 Ion Channels Human genes 0.000 description 2
239000012124 Opti-MEM Substances 0.000 description 2
208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241001494479 Pecora Species 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
241000700159 Rattus Species 0.000 description 2
241000725643 Respiratory syncytial virus Species 0.000 description 2
108010057163 Ribonuclease III Proteins 0.000 description 2
102000003661 Ribonuclease III Human genes 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
125000002252 acyl group Chemical group 0.000 description 2
238000007792 addition Methods 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000000621 bronchi Anatomy 0.000 description 2
210000003123 bronchiole Anatomy 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000034303 cell budding Effects 0.000 description 2
230000033077 cellular process Effects 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
238000011260 co-administration Methods 0.000 description 2
238000000975 co-precipitation Methods 0.000 description 2
238000000576 coating method Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000002716 delivery method Methods 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
229960002086 dextran Drugs 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
230000003325 follicular Effects 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
238000003205 genotyping method Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
208000037799 influenza C Diseases 0.000 description 2
108700010900 influenza virus proteins Proteins 0.000 description 2
230000010468 interferon response Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000002502 liposome Substances 0.000 description 2
239000008263 liquid aerosol Substances 0.000 description 2
230000004807 localization Effects 0.000 description 2
239000006166 lysate Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000012528 membrane Substances 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000003928 nasal cavity Anatomy 0.000 description 2
239000006199 nebulizer Substances 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
230000025308 nuclear transport Effects 0.000 description 2
239000002674 ointment Substances 0.000 description 2
230000008520 organization Effects 0.000 description 2
VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000007918 pathogenicity Effects 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
239000006187 pill Substances 0.000 description 2
230000036470 plasma concentration Effects 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000962 poly(amidoamine) Polymers 0.000 description 2
229920000747 poly(lactic acid) Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
150000003141 primary amines Chemical group 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
238000000746 purification Methods 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
239000011541 reaction mixture Substances 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
238000011269 treatment regimen Methods 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
229940045145 uridine Drugs 0.000 description 2
230000001018 virulence Effects 0.000 description 2
RIFDKYBNWNPCQK-IOSLPCCCSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-imino-3-methylpurin-9-yl)oxolane-3,4-diol Chemical compound C1=2N(C)C=NC(=N)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RIFDKYBNWNPCQK-IOSLPCCCSA-N 0.000 description 1
BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 description 1
125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 1
125000006728 (C1-C6) alkynyl group Chemical group 0.000 description 1
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
PISWNSOQFZRVJK-XLPZGREQSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 PISWNSOQFZRVJK-XLPZGREQSA-N 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 1
ZDTFMPXQUSBYRL-UUOKFMHZSA-N 2-Aminoadenosine Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ZDTFMPXQUSBYRL-UUOKFMHZSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
XXSIICQLPUAUDF-TURQNECASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XXSIICQLPUAUDF-TURQNECASA-N 0.000 description 1
WLZPCFOGJNCCRJ-UHFFFAOYSA-M 4-ethenyl-1-ethylpyridin-1-ium;bromide Chemical compound [Br-].CC[N+]1=CC=C(C=C)C=C1 WLZPCFOGJNCCRJ-UHFFFAOYSA-M 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 1
BXJHWYVXLGLDMZ-UHFFFAOYSA-N 6-O-methylguanine Chemical compound COC1=NC(N)=NC2=C1NC=N2 BXJHWYVXLGLDMZ-UHFFFAOYSA-N 0.000 description 1
UEHOMUNTZPIBIL-UUOKFMHZSA-N 6-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7h-purin-8-one Chemical compound O=C1NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UEHOMUNTZPIBIL-UUOKFMHZSA-N 0.000 description 1
HCJMNOSIAGSZBM-UHFFFAOYSA-N 6-methylsalicylic acid Chemical compound CC1=CC=CC(O)=C1C(O)=O HCJMNOSIAGSZBM-UHFFFAOYSA-N 0.000 description 1
HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 1
HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 1
208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 description 1
208000035657 Abasia Diseases 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
241000272814 Anser sp. Species 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
241000714230 Avian leukemia virus Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
108091032955 Bacterial small RNA Proteins 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
101000909256 Caldicellulosiruptor bescii (strain ATCC BAA-1888 / DSM 6725 / Z-1320) DNA polymerase I Proteins 0.000 description 1
241000282465 Canis Species 0.000 description 1
229920001661 Chitosan Polymers 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
206010014561 Emphysema Diseases 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000792859 Enema Species 0.000 description 1
241000709661 Enterovirus Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
241000711950 Filoviridae Species 0.000 description 1
241000287227 Fringillidae Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108091027305 Heteroduplex Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
241001500350 Influenzavirus B Species 0.000 description 1
101710128560 Initiator protein NS1 Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 1
101710089751 Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241000272168 Laridae Species 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
101710169959 Membrane protein 2 Proteins 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
241000351643 Metapneumovirus Species 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
235000015429 Mirabilis expansa Nutrition 0.000 description 1
244000294411 Mirabilis expansa Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
241000282339 Mustela Species 0.000 description 1
101150080862 NA gene Proteins 0.000 description 1
101150076514 NS gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
101800000512 Non-structural protein 1 Proteins 0.000 description 1
101710144127 Non-structural protein 1 Proteins 0.000 description 1
101800000511 Non-structural protein 2 Proteins 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
241000150452 Orthohantavirus Species 0.000 description 1
241000712464 Orthomyxoviridae Species 0.000 description 1
208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
102100040283 Peptidyl-prolyl cis-trans isomerase B Human genes 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
206010035737 Pneumonia viral Diseases 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 1
229920000388 Polyphosphate Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000288906 Primates Species 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
241000287531 Psittacidae Species 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
101000902592 Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) DNA polymerase Proteins 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
230000004570 RNA-binding Effects 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
241000220010 Rhode Species 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010081734 Ribonucleoproteins Proteins 0.000 description 1
102000004389 Ribonucleoproteins Human genes 0.000 description 1
CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
238000010818 SYBR green PCR Master Mix Methods 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000272534 Struthio camelus Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000725681 Swine influenza virus Species 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
108091034135 Vault RNA Proteins 0.000 description 1
108010065667 Viral Matrix Proteins Proteins 0.000 description 1
108010087302 Viral Structural Proteins Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000005336 allyloxy group Chemical group 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000009830 antibody antigen interaction Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
101150010487 are gene Proteins 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000003385 bacteriostatic effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000005284 basis set Methods 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
230000008512 biological response Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000000625 blastula Anatomy 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
125000001369 canonical nucleoside group Chemical group 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000007248 cellular mechanism Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
229910052729 chemical element Inorganic materials 0.000 description 1
210000003837 chick embryo Anatomy 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000006395 clathrin-mediated endocytosis Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000010372 cloning stem cell Methods 0.000 description 1
238000005354 coacervation Methods 0.000 description 1
210000002314 coated vesicle Anatomy 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229940028617 conventional vaccine Drugs 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
229940097362 cyclodextrins Drugs 0.000 description 1
108010048032 cyclophilin B Proteins 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
230000001461 cytolytic effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000000531 effect on virus Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000029142 excretion Effects 0.000 description 1
230000003631 expected effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
210000000887 face Anatomy 0.000 description 1
210000001752 female genitalia Anatomy 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000007789 gas Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000012226 gene silencing method Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
229940029575 guanosine Drugs 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
210000002989 hepatic vein Anatomy 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
230000005745 host immune response Effects 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000000879 imine group Chemical group 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
229940026289 infasurf Drugs 0.000 description 1
229960003971 influenza vaccine Drugs 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
230000010354 integration Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
238000007834 ligase chain reaction Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
244000144972 livestock Species 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
238000002493 microarray Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000008267 milk Substances 0.000 description 1
238000003801 milling Methods 0.000 description 1
235000013536 miso Nutrition 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
230000003843 mucus production Effects 0.000 description 1
239000006218 nasal suppository Substances 0.000 description 1
210000001989 nasopharynx Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
238000001668 nucleic acid synthesis Methods 0.000 description 1
230000005257 nucleotidylation Effects 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
239000007968 orange flavor Substances 0.000 description 1
210000003300 oropharynx Anatomy 0.000 description 1
229960003752 oseltamivir Drugs 0.000 description 1
QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
MCYTYTUNNNZWOK-LCLOTLQISA-N penetratin Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 MCYTYTUNNNZWOK-LCLOTLQISA-N 0.000 description 1
108010043655 penetratin Proteins 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
108010044156 peptidyl-prolyl cis-trans isomerase b Proteins 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229940065514 poly(lactide) Drugs 0.000 description 1
108010011110 polyarginine Proteins 0.000 description 1
239000008389 polyethoxylated castor oil Substances 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000001205 polyphosphate Substances 0.000 description 1
235000011176 polyphosphates Nutrition 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000001124 posttranscriptional effect Effects 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
244000144977 poultry Species 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000011045 prefiltration Methods 0.000 description 1
230000001023 pro-angiogenic effect Effects 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
239000003380 propellant Substances 0.000 description 1
229940048914 protamine Drugs 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
208000005069 pulmonary fibrosis Diseases 0.000 description 1
208000002815 pulmonary hypertension Diseases 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
239000012925 reference material Substances 0.000 description 1
210000005227 renal system Anatomy 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
238000012552 review Methods 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
229960000888 rimantadine Drugs 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
239000011435 rock Substances 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
238000010187 selection method Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
238000000935 solvent evaporation Methods 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000005563 spheronization Methods 0.000 description 1
238000001694 spray drying Methods 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
229940063649 survanta Drugs 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
230000009974 thixotropic effect Effects 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000006648 viral gene expression Effects 0.000 description 1
208000009421 viral pneumonia Diseases 0.000 description 1
230000006656 viral protein synthesis Effects 0.000 description 1
210000000605 viral structure Anatomy 0.000 description 1
239000005723 virus inoculator Substances 0.000 description 1
239000008215 water for injection Substances 0.000 description 1